Patent · US Expired

Substituted aryl 1,4-pyrazine derivatives

US6992087B2 · kind B2 · utility

61Cited by
4References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 15, 2002
Grant dateJan 31, 2006
Priority date
Expiry dateJan 12, 2023

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S206/828
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Substituted aryl 1,4-pyrazine derivatives of formula I as defined herein and their use in treating anxiety disorders, depression and stress related disorders are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.